3
Announcements
Trials
Browse
Landscape
Sponsor
Conditions
Prostatic Neoplasms
28
Neoplasm Metastasis
3
Carcinoma, Non-Small-Cell Lung
2
Urogenital Neoplasms
1
Squamous Cell Carcinoma of Head and Neck
1
Solid Tumours
1
Small Cell Lung Carcinoma
1
Prostatic Neoplasms, Castration-Resistant
1
Primary Myelofibrosis
1
Pancreatic Neoplasms
1
Ovarian Neoplasms
1
Newly Diagnosed Oligometastatic Prostate Cancer
1
Neoplasms
1
Myeloproliferative Disorders
1
Myelodysplastic Syndromes
1
Multiple Myeloma
1
Metastatic Castration-resistant Prostate Cancer
1
Metastatic Castration-Resistant Prostate Cancer
1
Metastatic Castration Resistant Prostate Cancer
1
Melanoma
1
Lymphoma, Non-Hodgkin
1
Lymphoma, Large B-Cell, Diffuse
1
Lymphoma
1
Leukemia
1
Glioblastoma
1
Colorectal Neoplasms
1
Carcinoma, Small Cell
1
Breast Neoplasms
1
Anus Neoplasms
1
Interventions
fludarabine phosphate
32
Peripheral Blood Stem Cell Transplantation
27
Tacrolimus
26
Cyclophosphamide
26
Whole-Body Irradiation
25
Busulfan
21
Mycophenolic Acid
20
Methotrexate
16
Antilymphocyte Serum
16
Melphalan
12
Cyclosporine
9
Cord Blood Stem Cell Transplantation
8
Filgrastim
7
Etoposide
7
Thiotepa
6
thymoglobulin
5
merphos
5
Sirolimus
5
Rituximab
5
Radiotherapy
5
Methylprednisolone
5
Cytarabine
5
Granulocyte Colony-Stimulating Factor
4
sargramostim
3
fludarabine
3
Flow Cytometry
3
Transplantation
2
Polymerase Chain Reaction
2
Ondansetron
2
Imatinib Mesylate
2
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
0 trials
Recent
Start date
Enrollment
Has results
×
Leukemia, Myeloid, Accelerated Phase
×
abiraterone
×
Clear all
No trials found.